PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
31-Oct-2024 PRODUCTLIFE GROUP (PLG) ACQUIRES CALLISTO TO STRENGTHEN REGULATORY SERVICES IN THE UK AND EU PRODUCTLIFE GROUP
31-Oct-2024 Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update Immunic AG
31-Oct-2024 Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) Takeda Pharmaceutical Company Limited
30-Oct-2024 Management Board and Supervisory Board of APONTIS PHARMA AG recommend accepting Zentiva’s public tender offer APONTIS PHARMA AG
30-Oct-2024 Evotec SE to announce results for the first nine months 2024 on 06 November 2024 Evotec SE
30-Oct-2024 Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow SYNLAB AG
29-Oct-2024 Dr. Falk Pharma acquires spinout Kynos Therapeutics to develop novel KMO inhibitors for acute pancreatitis Edinburgh Innovations
29-Oct-2024 Almirall launches the campaign “Me & My Inner Circle” to acknowledge the vital role of friends and family for people living with psoriasis Almirall
29-Oct-2024 Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor Pentixapharm Holding AG
29-Oct-2024 Immunic to Participate in Industry, Scientific and Investor Conferences in November Immunic AG
29-Oct-2024 Biotest and SteinCares partner to improve access to plasma-derived products in Latin America Biotest AG
29-Oct-2024 Drägerwerk AG & Co. KGaA: Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024 Drägerwerk AG & Co. KGaA
29-Oct-2024 Evolva Holding AG publishes half-year report 2024 and IFRS annual report 2023 Evolva Holding SA
29-Oct-2024 Strong organic revenue growth in the third quarter Straumann Holding AG
29-Oct-2024 Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE Relief Therapeutics Holding SA
28-Oct-2024 Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion Corporation
28-Oct-2024 CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting CureVac
28-Oct-2024 Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG Pentixapharm Holding AG
28-Oct-2024 2nd Global Summit on Vaccines and Immunology(GSVI2025) Apex Global Meetings
25-Oct-2024 HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024 HighTide Therapeutics